0
2021
Transcatheter Aortic Valve Implantation (tavi) Market

Transcatheter Aortic Valve Implantation (TAVI) Market

by Procedure (Transfemoral Procedure, Subclavian Procedure, and Others): Global Opportunity Analysis and Industry Forecast, 2021--2030

Report Code: A01350
Nov 2021 | Pages: 145
Tables: 43
Charts: 43
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Transcatheter Aortic Valve Implantation (tavi) Market

Request Now !

Transcatheter Aortic Valve Implantation (TAVI) Market Study:

The global transcatheter aortic valve implantation market was valued at $4,559 million in 2020, and is estimated to reach $16,937 million by 2030, growing at a CAGR of 14.0% from 2021 to 2030. Transcatheter aortic valve implantation is defined as a minimally invasive procedure in which a narrowed aortic valve is replace and it is an open heart surgery. It is used for the treatment of aortic stenosis. 

Aortic stenosis is a disease in which an aortic valve does not open fully will restrict blood flow. An aorta is a large artery which carries blood from heart to rest of the body. These high-risk patients refer to the patient population that are inoperable and cannot undergo surgical aortic valve replacement (SAVR) procedure. Older population (above 75 years of age) falls under the high-risk category, as the open-heart procedure is too risky for them. TAVR involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise due to the increase in prevalence of aortic stenosis. 

Transcatheter-Aortic-Valve-Implantation-Market

Growth of the transcatheter aortic valve implantation market is majorly driven by increase in prevalence of aortic stenosis, rise in demand for various TAVI procedures, and advancements in technologies in the field of transcatheter aortic valve implantation. In addition, rise in geriatric population fuels the TAVI market growth, owing to the fact that aged individuals are more susceptible to aortic stenosis. In addition, technological advancements in TAVI valve and rise in awareness regarding early diagnosis propel the growth of the market.  

However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices, and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and increase in interest of key players in the global transcatheter aortic valve implantation (TAVI) industry are projected to provide several growth opportunities for the market throughout the forecast period.

Transcatheter Aortic Valve Implantation (TAVI) Market Segmentation

The global transcatheter aortic valve implantation market is segmented into procedure type, and region. By procedure, the market is categorized into transfemoral subclavian procedure, and others.

Region-wise, the TAVI market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Switzerland, and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Israel Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review

Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to positive outcomes. However, this implantation has some complications due to greater distance of insertion from the aortic valve. 

Transfemoral implantation is stated as the standardized TAVI procedure, where in artificial valve is implanted through the femoral artery with minimal anesthesia. However, there are several patients, who have weak and small arteries, so are unable to undergo transfemoral TAVI. In this case, transapical implantation is preferred, wherein the artificial valve is inserted through the left ventricular apex. Furthermore, transaortic implantation is developed for patients who have weak femoral arteries and poor respiratory function, which makes them unsuitable for transfemoral as well as transapical TAVI procedure as well.

Europe garnered a major share in the transcatheter aortic valve implantation market in 2020, and is expected to continue to dominate during the forecast period, owing to presence of key players, developed healthcare sector, and advancement in technology for TAVI valve in the region. The growth in the European TAVI market is attributed to the increase in prevalence of severe aortic stenosis cases coupled with the growth in high-risk patients and the rise in awareness among patients and physicians about the availability of advanced transcatheter aortic valves. In addition, favorable reimbursement policies in certain European nations is the key to increase the adoption of TAVI procedures in this region. 

Germany accounted for the maximum number of the TAVI procedures in the whole Europe. In addition, supportive regulations for the TAVI devices in the country are projected to propel the market growth.  The prevalence of symptomatic aortic stenosis is substantial in the UK and is expected to grow in future due to the growth in the number of high-risk aortic stenosis patients in the country. This number is expected to increase due to changes in lifestyles of the people, which include unhealthy dietary habits, lack of physical activity, and smoking. In addition, favorable reimbursement scenario of the UK further propels the TAVI market. 

Transcatheter Aortic Valve Implantation (TAVI) Market
By Procedure Type

Your browser does not support the canvas element.

Transfemoral segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Asia-Pacific is expected to register the highest CAGR over forecast period, owing to increase in prevalence of aortic stenosis diseases, developing healthcare infrastructure, and rise in awareness related to transcatheter aortic valve implantation. Asia-Pacific offer lucrative opportunities for players operating in the transcatheter aortic valve implantation market, attributable to its large population base along with several cardiovascular, & lifestyle diseases. Moreover, increase in number of transfemoral TAVI procedures in emerging economies such as India and China are the major factors that boost the market growth.

Conversely, lesser availability of transcatheter aortic valve implantation services and lower diagnostic yield, especially in remote areas of emerging nations, is expected to hinder the market growth. Furthermore, insurance companies do not completely cover treatment expenses for transcatheter aortic valve implantation services in the region, which is expected to restrain the market growth in Asia-Pacific.

Transcatheter Aortic Valve Implantation (TAVI) Market
By Region

2030
Europe 
North America
Asia-Pacific
LAMEA

North America is expected to experience growth at the highest rate, registering a CAGR of 14.10 % during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the transcatheter aortic valve implantation (TAVI) market, and the current trends & future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing TAVI market opportunities.
  • Extensive analysis of the market based on procedures and region assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Transcatheter Aortic Valve Implantation (TAVI) Market Report Highlights

Aspects Details
By Procedure
  • Transfemoral Procedure
  • Subclavian Procedure
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Switzerland, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Israel, Saudi Arabia, South Africa, Rest of LAMEA)
By Key Market Players
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Blue Sail Medical Co. Ltd.
  • Bracco
  • Edward Lifesciences
  • JC Medical Inc.
  • JenaValve Techologies Inc.
  • Medtronic Plc
  • Meril Lifesciences
  • Venus Medtech
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
Secondary research
Primary research
Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings
Top investment pockets
Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.6.Impact analysis of COVID-19 on the TAVI market

CHAPTER 4:MINIMALLY INVASIVE SURGERY MARKET, BY PROCEDURE

4.1.Overview

4.1.1.Market size and forecast

4.2.Transfemoral Procedure

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Subclavian Procedure

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

4.4.Others

4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast, by region

CHAPTER 5:TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast, by region

5.2.North America

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.North America transcatheter aortic valve implantation market, by procedure
5.2.3.Market size and forecast, by country

5.2.3.1.U.S.
5.2.3.2.Canada
5.2.3.3.Mexico

5.3.Europe

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Europe transcatheter aortic valve implantation market, by procedure
5.3.3.Market size and forecast, by country

5.3.3.1.Germany
5.3.3.2.France
5.3.3.3.UK
5.3.3.4.Italy
5.3.3.5.Switzerland
5.3.3.6.Rest of Europe

5.4.Asia-Pacific

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Asia-Pacific transcatheter aortic valve implantation  market, by procedure
5.4.3.Market size and forecast, by country

5.4.3.1.Japan
5.4.3.2.China
5.4.3.3.India
5.4.3.4.Rest of Asia-Pacific

5.5.LAMEA

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.LAMEA transcatheter aortic valve implantation  market, by procedure
5.5.3.Market size and forecast, by country

5.5.3.1.Brazil
5.5.3.2.Israel
5.5.3.3.South Africa
5.5.3.4.Saudi Arabia
5.5.3.5.Rest of LAMEA

CHAPTER 6:COMPANY PROFILES: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET

6.1.ABBOTT LABORATORIES

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.1.6.Key strategic moves and developments

6.2.BLUE SAIL MEDICAL CO. LTD (BIOSENSERS INTERNATIONAL)

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
Key strategic moves and developments

6.3.BOSTON SCINENTIFIC CORPORATION

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance
6.3.6.Key strategic moves and developments

6.4.BRACCO (HLT INC.)

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Key strategic moves and developments

6.5.EDWARD LIFE SCIENCES

6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product portfolio
6.5.5.Business performance
6.5.6.Key strategic moves and developments

6.6.JC MEDICAL INC.

6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio

6.7.JENA VALVE

6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Product portfolio

6.8.MEDTRONIC PLC

6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Business performance
6.8.6.Key strategic moves and developments

6.9.MERIL

6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Key strategic moves and developments

6.10.VENUS MEDTECH

6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Product Portfolio
6.10.4.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL TRANSCATHER AORITC VALVE IMPLANTATION MARKET, BY PROCEDURE, 2020–2030 ($MILLION)
TABLE 02.GLOBAL TRANSCATHER AORITC VALVE IMPLANTATION MARKET VOLUME, BY PROCEDURE, 2020–2030 (UNITS)
TABLE 03.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET FOR TRANSFEMORAL PROCEDURE, BY REGION, 2020–2030 ($MILLION)
TABLE 04.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET FOR TRANSFEMORAL PROCEDURE VOLUME, BY REGION, 2020–2030 (UNITS)
TABLE 05.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET FOR SUBCLAVIAN PROCEDURE, BY REGION, 2020–2030 ($MILLION)
TABLE 06.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET FOR SUBCLAVIAN PROCEDURE VOLUME, BY REGION, 2020–2030 (UNITS)
TABLE 07.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET FOR OTHER PROCEDURES, BY REGION, 2020–2030 ($MILLION)
TABLE 08.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET FOR OTHER PROCEDURES VOLUME, BY REGION, 2020–2030 ($MILLION)
TABLE 09.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 10.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, VOLUME BY REGION, 2020-2030 (UNITS)
TABLE 11.NORTH AMERICA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 12.NORTH AMERICA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET VOLUME, BY PROCEDURE 2020-2030 (UNITS)
TABLE 13.NORTH AMERICA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 14.NORTH AMERICA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET VOLUME BY COUNTRY, 2020-2030 (UNITS)
TABLE 15.EUROPE TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 16.EUROPE TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, VOLUME BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 17.EUROPE TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18.EUROPE TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET VOLUME BY COUNTRY, 2020-2030 (UNITS)
TABLE 19.ASIA-PACIFIC TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 20.ASIA-PACIFIC TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, VOLUME BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 21.ASIA-PACIFIC TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22.ASIA-PACIFIC TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET VOLUME, BY COUNTRY, 2020-2030 (UNITS)
TABLE 23.LAMEA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 24.LAMEA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, VOLUME BY PROCEDURE, 2020-2030 ($MILLION)
TABLE 25.LAMEA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 26.LAMEA TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 27.ABBOTT: COMPANY SNAPSHOT
TABLE 28.ABBOTT: OPERATING SEGMENTS
TABLE 29.ABBOTT : PRODUCT PORTFOLIO
TABLE 30.BLUE SAIL COMPANY SNAPSHOT
TABLE 31.BLUE SAIL OPERATING SEGMENTS
TABLE 32.BLUE SAIL: PRODUCT PORTFOLIO
TABLE 33.BOSTON: COMPANY SNAPSHOT
TABLE 34.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 35.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 36.BRACCO: COMPANY SNAPSHOT
TABLE 37.BRACCO: OPERATING SEGMENTS
TABLE 38.BRACCO: PRODUCT PORTFOLIO
TABLE 39.EDWARDS: COMPANY SNAPSHOT
TABLE 40.EDWARDS OPERATING SEGMENTS
TABLE 41.EDWARDS: PRODUCT PORTFOLIO
TABLE 42.JC MEDICAL: COMPANY SNAPSHOT
TABLE 43.JC MEDICAL: OPERATING SEGMENTS
TABLE 44.JC MEDICAL: PRODUCT PORTFOLIO
TABLE 45.JENA VALVE: COMPANY SNAPSHOT
TABLE 46.JENA VALVE: PRODUCT PORTFOLIO
TABLE 47.MEDTRONIC: COMPANY SNAPSHOT
TABLE 48.MEDTRONIC: OPERATING SEGMENTS
TABLE 49.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 50.MERIL: COMPANY SNAPSHOT
TABLE 51.MERIL: OPERATING SEGMENTS
TABLE 52.MERIL: PRODUCT PORTFOLIO
TABLE 53.VENUS MEDTECH: COMPANY SNAPSHOT
TABLE 54.VENUS MEDTECH: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.U.S: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 14.CANADA: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 15.MEXICO: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 16.GERMANY TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 17.FRANCE TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 18.U.K. TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 19.ITALY TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 20.SWITZERLAND TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 21.REST OF EUROPE TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 22.JAPAN: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 23.CHINA: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 24.INDIA: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 25.REST OF ASIA-PACIFIC: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 26.BRAZIL: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 27.ISRAEL: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 28.SOUTH AFRICA: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 29.SAUDI ARABIA: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 30.REST OF LAMEA: TAVI MARKET (VALUE AND VOLUME), 2020-2030
FIGURE 31.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.EDWARDS: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.EDWARDS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.EDWARDS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
Figure 43.Medtronic: Revenue share by region, 2020 (%)


 
 

Rise in demand for TAVI procedure is due to increase in prevalence of symptomatic aortic stenosis coupled with expanding population of high risk or inoperable patients. Furthermore, the key players of the market aim to develop technologically advanced transcatheter aortic valves with increased clinical indications. Moreover, Europe is projected to be the highest revenue contributor, whereas Asia-Pacific is expected to offer lucrative opportunities to the key players in this market.

Rise in geriatric population prone to aortic stenosis, technological advancements in transcatheter aortic valves, and increased adoption rate of TAVI procedure are some of the major factors that drive the TAVI market. However, stringent regulatory norms of the government hamper the market growth. Currently, transfemoral implantation segment occupies the largest share in the global TAVI market, followed by subclavian implantation. Europe is expected to dominate the global TAVI market during the forecast period, followed by North America.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of transcatheter aortic valve implantation market is $4,558.5 million in 2020.

A. The forcast period for transcatheter aortic valve implantation market is 2021 to 2030

A. The market value of transcatheter aortic valve implantation market in 2021 is $5,214.6 million.

A. The base year is 2020 in transcatheter aortic valve implantation market.

A. Top companies such as Abbott Laboratories, Blue Sail Medical, Boston Scientific Corporation, Bracco, Edward Life Sciences, JC Medical, JenaValve, Medtronic Plc, Meril Life Sciences and Venus MedTech held a high market position in 2020.

A. Transfemoral segment is the most influencing segment owing to increase in standard care for aortic stenosis, it is a less invasive procedure and offers shortened recovery time.

A. Increase in the prevalence of aortic stenosis, advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices.

A. Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to presence of ample of growth opportunities in terms of unmet medical needs for the treatment of aortic stenosis in this region.

A. Transcatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis.

A. Transcatheter aortic valve implantation is a minimally invasive heart procedure to replace thickened aortic valve. TAVI helps to restore blood flow and reduce the signs and symptoms of aortic valve stenosis such as shortness of breath, fainting and fatigue and, chest pain.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Transcatheter Aortic Valve Implantation (tavi) Market

Start reading instantly.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Nov 2022 - Nov 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2022 - Nov 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2022 - Nov 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2022 - Nov 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2022 - Nov 2023)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers